AdvanCell
Entry
2025
Hold
1yr
Status
Active
Who owns AdvanCell?
AdvanCell is currently owned by Abingworth through Abingworth Bioventures 8 (2021 vintage), since 2025. Across its history, AdvanCell has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-06-07
Most recent investor
AbingworthAbingworth Bioventures 8 · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQAustralia
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2025 · present
SV Health ManagersActive
2025 · present(1yr) · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
AbingworthActive
2025 · present(1yr) · Abingworth Bioventures 8 · 2021 · Life Sciences VC
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
UK
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack AdvanCell
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on AdvanCell.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue